Levi & Korsinsky Reminds Regeneron Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 10, 2025 - REGN
Portfolio Pulse from
Levi & Korsinsky has announced a class action lawsuit against Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) for alleged securities fraud affecting investors between November 2, 2023, and October 30, 2024. The lead plaintiff deadline is March 10, 2025.
February 28, 2025 | 11:00 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Regeneron Pharmaceuticals is facing a class action lawsuit for alleged securities fraud, which could impact investor confidence and stock price. The lawsuit covers the period from November 2, 2023, to October 30, 2024.
The announcement of a class action lawsuit for alleged securities fraud is likely to negatively impact Regeneron's stock price in the short term. Legal issues can lead to uncertainty and reduced investor confidence, potentially causing a sell-off.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100